cytarabine has been researched along with threonine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerron, GG; Howard, CH; Rudman, D; Vogler, WR | 1 |
De Leon, G; Krucher, NA; Roberts, MH; Rubin, E; Sherry, TC; Tedesco, VC | 1 |
Craig, RW; De Biasio, A; Domina, AM; Gregory, MA; Gui, J; Hann, SR; Nifoussi, SK; Vrana, JA | 1 |
3 other study(ies) available for cytarabine and threonine
Article | Year |
---|---|
Observations on the plasma amino acids of patients with acute leukemia.
Topics: Acute Disease; Alanine; Amino Acids; Asparaginase; Cytarabine; Glucocorticoids; Glutamine; Histidine; Humans; Indicators and Reagents; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Methionine; Methotrexate; Nitrogen; Proline; Threonine; Vincristine | 1971 |
Dephosphorylation of Rb (Thr-821) in response to cell stress.
Topics: Antimetabolites, Antineoplastic; Cell Cycle; Cell Hypoxia; Cytarabine; DNA-Binding Proteins; Epithelial Cells; Female; Humans; Nuclear Proteins; Phosphoprotein Phosphatases; Phosphorylation; Protein Subunits; Retinoblastoma Protein; RNA-Binding Proteins; Threonine; Tumor Cells, Cultured | 2006 |
Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; CHO Cells; Cisplatin; Cricetinae; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Flow Cytometry; Glycogen Synthase Kinase 3; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; Protein Stability; Proto-Oncogene Proteins c-bcl-2; Threonine; Vinblastine | 2012 |